Results 321 to 330 of about 176,935 (377)

Clinical Characteristics and Outcomes of Patients With Rome IV Functional Dyspepsia Who Consume Opioids: A Real‐World Study

open access: yesNeurogastroenterology &Motility, EarlyView.
Approximately one in three patients with Rome IV functional dyspepsia (FD) consume opioids and this is associated with older age, depression/anxiety, and chronic pain. Opioid cessation alongside a neuromodulator improved symptoms in 29% of cases, with a number needed to treat of 5.7, suggesting that this treatment strategy may be beneficial in FD ...
Mohsin F. Butt   +9 more
wiley   +1 more source

Targeting LncRNA-Vof16: A Novel Therapeutic Strategy for Neuropathic Pain Relief. [PDF]

open access: yesCNS Neurosci Ther
He X   +8 more
europepmc   +1 more source

Effectiveness of Systemic Corticosteroids in Managing Cancer-Related Neuropathic Pain: A Multicenter Prospective Observational Study. [PDF]

open access: yesCancers (Basel)
Tagami K   +26 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy